Literature DB >> 23337596

Understanding drugs and diseases by systems biology?

Hans-Christoph Schneider1, Thomas Klabunde.   

Abstract

Systems biology aims to provide a holistic and in many cases dynamic picture of biological function and malfunction, in case of disease. Technology developments in the generation of genome-wide datasets and massive improvements in computer power now allow to obtain new insights into complex biological networks and to copy nature by computing these interactions and their kinetics and by generating in silico models of cells, tissues and organs. The expectations are high that systems biology will pave the way to the identification of novel disease genes, to the selection of successful drug candidates--that do not fail in clinical studies due to toxicity or lack of human efficacy--and finally to a more successful discovery of novel therapeutics. However, further research is necessary to fully unleash the potential of systems biology. Within this review we aim to highlight the most important and promising top-down and bottom-up systems biology applications in drug discovery.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23337596     DOI: 10.1016/j.bmcl.2012.12.031

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis.

Authors:  He Shen; Nuo Yang; Alexander Truskinovsky; Yanmin Chen; Ashley L Mussell; Norma J Nowak; Lester Kobzik; Costa Frangou; Jianmin Zhang
Journal:  Mol Cancer Res       Date:  2018-09-20       Impact factor: 5.852

2.  Fetal alcohol syndrome, chemo-biology and OMICS: ethanol effects on vitamin metabolism during neurodevelopment as measured by systems biology analysis.

Authors:  Bruno César Feltes; Joice de Faria Poloni; Itamar José Guimarães Nunes; Diego Bonatto
Journal:  OMICS       Date:  2014-05-09

3.  Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders.

Authors:  Anje A Te Velde; Tjitske Bezema; Antoine H C van Kampen; Aletta D Kraneveld; Bert A 't Hart; Henriët van Middendorp; Erik C Hack; Joris M van Montfrans; Clara Belzer; Lilian Jans-Beken; Raymond H Pieters; Karen Knipping; Machteld Huber; Annemieke M H Boots; Johan Garssen; Tim R Radstake; Andrea W M Evers; Berent J Prakken; Irma Joosten
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

Review 4.  Integrative approach in the era of failing drug discovery and development.

Authors:  Keehyun Earm; Yung E Earm
Journal:  Integr Med Res       Date:  2014-09-10

5.  UNaProd: A Universal Natural Product Database for Materia Medica of Iranian Traditional Medicine.

Authors:  Ayeh Naghizadeh; Donya Hamzeheian; Shaghayegh Akbari; Fahimeh Mohammadi; Tohid Otoufat; Saeme Asgari; Azadeh Zarei; Samane Noroozi; Najmeh Nasiri; Mahdi Salamat; Reza Karbalaei; Mehdi Mirzaie; Hossein Rezaeizadeh; Mehrdad Karimi; Mohieddin Jafari
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-13       Impact factor: 2.629

6.  Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises.

Authors:  Austė Kanapeckaitė; Asta Mažeikienė; Liesbet Geris; Neringa Burokienė; Graeme S Cottrell; Darius Widera
Journal:  Biophys Chem       Date:  2022-09-11       Impact factor: 3.628

Review 7.  Drug Repositioning for Effective Prostate Cancer Treatment.

Authors:  Beste Turanli; Morten Grøtli; Jan Boren; Jens Nielsen; Mathias Uhlen; Kazim Y Arga; Adil Mardinoglu
Journal:  Front Physiol       Date:  2018-05-15       Impact factor: 4.566

Review 8.  Taking Bioinformatics to Systems Medicine.

Authors:  Antoine H C van Kampen; Perry D Moerland
Journal:  Methods Mol Biol       Date:  2016
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.